IP Library Granted Patent US 8,981,044
Granted Patent B2
US 8,981,044 · App. 13/641,812 · Granted Mar 17, 2015

Lipid membrane structure having intranuclear migrating property

Inventors: Hideyoshi Harashima (Hokkaido, JP); Hidetaka Akita (Hokkaido, JP); Mohammad Shaheen Sharif (Hokkaido, JP); Takashi Nakamura (Hokkaido, JP); Soichiro Ishii (Hokkaido, JP); Shiroh Futaki (Kyoto, JP)
Assignee: National University Corporation Hokkaido University
A61K47/42A61K9/127A61K9/1272A61K31/711A61K39/39A61K47/48A61K47/48238A61K47/48815A61K48/0041C12N15/00C12N15/88A61K2039/55555A61K2039/5154C12N2810/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,981,044
App. No.
13/641,812
Granted
Mar 17, 2015
Kind
B2
Abstract

A lipid membrane structure for delivering a substance into a nucleus of a cell, wherein lipid membrane is modified with (a) a polypeptide comprising the amino acid sequence of SEQ ID NO: 1, and/or (b) a polypeptide consisting of an amino acid sequence comprising the amino acid sequence of SEQ ID NO: 1, but including deletion and/or substitution and/or insertion of one or several amino acid residues, and having an activity of promoting migration of the lipid membrane structure into a nucleus of a cell, which can efficiently deliver a nucleic acid into a nucleus of an immunocyte such as dendritic cell.

Claims (11)

1. A lipid membrane structure for delivering a substance into a nucleus of a cell that encapsulates the substance to be delivered and that is modified with a polypeptide having amino acid residues which consist of the amino acid residues in the amino acid sequence of SEQ ID NO: 1.

2. The lipid membrane structure according to claim 1 , wherein the lipid membrane structure is a liposome.

3. The lipid membrane structure according to claim 1 , wherein the polypeptide is modified with a hydrophobic group, and the hydrophobic group is inserted into the lipid membrane.

4. The lipid membrane structure according to claim 1 , which has a polypeptide containing a plurality of contiguous arginine residues on the surface.

5. The lipid membrane structure according to claim 1 , which has a polyalkylene glycol on the surface.

6. The lipid membrane structure according to claim 1 , wherein a nucleic acid and a cationic polymer are enclosed in the inside of the lipid membrane structure.

7. The lipid membrane structure according to claim 1 , wherein the substance to be delivered is a nucleic acid encoding an antigen polypeptide to be presented on the surface of an immunocyte.

8. The lipid membrane structure according to claim 7 , wherein the nucleic acid is DNA, and the DNA does not contain CpG.

9. A pharmaceutical composition containing the lipid membrane structure according to claim 1 as an active ingredient.

10. A polypeptide

having amino acid residues which consist of the amino acid residues in the amino acid sequence of SEQ ID NO: 1.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2016
From: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
To: NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY
Reel/Frame 039587/0329 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2013
From: HARASHIMA, HIDEYOSHI; AKITA, HIDETAKA; SHARIF, MOHAMMAD SHAHEEN; NAKAMURA, TAKASHI; ISHII, SOICHIRO; FUTAKI, SHIROH
To: NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
Reel/Frame 029670/0865 →
Priority Claims (1)
JP 2010-097888 · Apr 21, 2010 · national
Continuity (1)
Related Publication 20130122054A1 · May 16, 2013